JYNT
JOINT Corp
Company overview
- Market capitalization
- $114.56M
- Employees
- 202
- Latest publication
- 2026-09-29
About JOINT Corp
The Joint Corp. operates and is a franchisor and operator of chiropractic clinics in the United States. The company provides services under the franchise agreement, including training of franchisees and staff, site selection, construction/vendor management and ongoing operations support. It operates through a network of franchised clinics, offering routine and affordable chiropractic adjustments using a private pay, non-insurance, cash-based model. The company was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q4 20232023-12-31 · USD | Q3 20232023-09-30 · USD | Q2 20232023-06-30 · USD | Q1 20232023-03-31 · USD | Q4 20222022-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 14,820,233USD | 15,167,047USD | 13,380,685USD | 30,614,403USD | 29,473,949USD | 29,307,184USD | 28,300,820USD | 27,812,553USD |
| Cost Of Revenue | 3,119,348USD | 2,819,507USD | 2,661,234USD | 2,872,262USD | 2,604,100USD | 2,595,512USD | 2,474,685USD | 2,600,070USD |
| Gross Profit | 11,700,885USD | 12,347,540USD | 10,719,451USD | 27,742,141USD | 26,869,849USD | 26,711,672USD | 25,826,135USD | 25,212,483USD |
| Selling General Administrative | 7,084,986USD | 7,676,121USD | 7,104,142USD | 21,310,066USD | 20,212,750USD | 19,904,796USD | 20,038,476USD | 18,284,031USD |
| Selling And Marketing Expenses | 3,716,904USD | 3,494,324USD | 2,816,081USD | 3,372,911USD | 4,301,017USD | 4,707,818USD | 4,160,244USD | 3,296,209USD |
| Total Operating Expenses | 10,801,890USD | 11,603,645USD | 10,558,536USD | 27,889,517USD | 27,767,896USD | 27,086,226USD | 26,479,244USD | 23,932,875USD |
| Operating Income | 898,995USD | 743,895USD | 160,915USD | -147,376USD | -898,047USD | -374,554USD | -653,109USD | 1,279,608USD |
| Income Before Tax | 1,113,903USD | 940,642USD | 300,716USD | -143,932USD | -904,291USD | -481,074USD | 3,168,053USD | 1,207,175USD |
| Income Tax Expense | 11,112USD | 3,513USD | 10,346USD | 10,897,667USD | -188,018USD | -160,585USD | 841,889USD | 659,983USD |
| Tax Provision | 11,112USD | 3,513USD | 10,346USD | 10,897,667USD | -188,018USD | -290,691USD | 841,889USD | 659,983USD |
| Net Income | 1,299,135USD | 991,097USD | 855,009USD | -11,041,599USD | -716,273USD | -320,489USD | 2,326,164USD | 547,192USD |
| Net Income From Continuing Ops | 1,102,791USD | 937,129USD | 290,370USD | -11,041,599USD | -716,273USD | -190,383USD | 2,301,036USD | 547,192USD |
| Ebit | 1,113,903USD | 940,642USD | 300,716USD | 1,370,490USD | 6,876USD | -230,209USD | -587,640USD | 1,329,683USD |
| Ebitda | 1,510,596USD | 1,383,585USD | 763,762USD | 3,059,164USD | 2,356,083USD | 2,099,058USD | 1,627,415USD | 3,632,243USD |
| Depreciation And Amortization | 396,693USD | 442,943USD | 463,046USD | 1,688,674USD | 2,349,207USD | 2,329,267USD | 2,215,055USD | 2,302,560USD |
| Reconciled Depreciation | 404,449USD | 442,943USD | 463,046USD | 1,688,674USD | 2,349,207USD | 2,201,778USD | 2,342,544USD | 2,302,560USD |
| Total Other Income Expense Net | 214,908USD | 196,747USD | 139,801USD | 3,444USD | -6,244USD | -106,520USD | 3,821,162USD | -72,433USD |
| Unclassified Operating Expenses | — | — | — | 3,206,540USD | 3,254,129USD | 2,473,612USD | 2,280,524USD | 2,352,635USD |
| Interest Expense | — | — | — | 3,669,043USD | 6,244USD | 14,937USD | 3,690,224USD | 172,583USD |
| Net Income Applicable To Common Shares | — | — | — | — | — | -320,489USD | 2,301,036USD | 547,192USD |
| Non Operating Income Net Other | — | — | — | — | — | — | 3,821,162USD | -72,433USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD | FY 20132013-12-31 · USD |
|---|---|---|---|---|---|---|
| Total Revenue | 101,252,310USD | 80,011,013USD | 58,682,976USD | 48,450,900USD | 31,789,249USD | 5,958,067USD |
| Cost Of Revenue | 9,171,063USD | 7,665,138USD | 6,507,468USD | 5,565,917USD | 4,310,249USD | 2,006,196USD |
| Gross Profit | 92,081,247USD | 72,345,875USD | 52,175,508USD | 42,884,983USD | 27,479,000USD | 3,951,871USD |
| Selling General Administrative | 67,987,482USD | 50,846,818USD | 36,195,817USD | 30,543,030USD | 20,304,131USD | 2,660,101USD |
| Selling And Marketing Expenses | 13,962,709USD | 11,424,416USD | 7,804,420USD | 6,913,709USD | 4,819,555USD | 781,256USD |
| Unclassified Operating Expenses | 9,302,802USD | 3,948,676USD | 2,683,141USD | 2,013,609USD | 1,213,240USD | — |
| Total Operating Expenses | 91,252,993USD | 66,219,910USD | 46,683,378USD | 39,470,348USD | 26,679,926USD | 3,512,082USD |
| Operating Income | 828,254USD | 6,125,965USD | 5,492,130USD | 3,414,635USD | 205,114USD | 439,789USD |
| Interest Expense | 953,531USD | 133,548USD | 23,164USD | 251,623USD | 0USD | 0USD |
| Income Before Tax | 695,153USD | 6,056,087USD | 5,412,652USD | 3,372,418USD | 215,355USD | 407,789USD |
| Income Tax Expense | 68,448USD | -1,508,960USD | -7,754,662USD | 48,706USD | -37,728USD | 252,154USD |
| Tax Provision | 766,510USD | -1,220,669USD | -7,754,662USD | 48,706USD | -37,728USD | — |
| Net Income | 626,705USD | 7,565,047USD | 13,167,314USD | 3,323,712USD | 253,083USD | 155,635USD |
| Net Income From Continuing Ops | 1,177,250USD | 7,159,307USD | 13,167,314USD | 3,323,712USD | 253,083USD | — |
| Ebit | 1,238,469USD | 6,152,754USD | 5,440,809USD | 3,528,987USD | 737,495USD | 439,789USD |
| Ebitda | 7,885,091USD | 10,074,641USD | 8,175,271USD | 5,428,244USD | 2,293,735USD | 510,514USD |
| Depreciation And Amortization | 6,646,622USD | 3,921,887USD | 2,734,462USD | 1,899,257USD | 1,556,240USD | 70,725USD |
| Reconciled Depreciation | 7,643,980USD | 6,088,947USD | 2,734,462USD | 1,899,257USD | 1,556,240USD | — |
| Total Other Income Expense Net | -133,101USD | -69,878USD | -79,478USD | -42,217USD | -33,593USD | -32,000USD |
| Non Operating Income Net Other | -133,101USD | -69,878USD | -79,478USD | -42,217USD | 10,241USD | — |
| Net Income Applicable To Common Shares | 1,177,250USD | 7,159,307USD | 13,167,314USD | 3,323,712USD | 253,083USD | 156,000USD |
| Minority Interest | — | — | 100USD | 100USD | 100USD | — |
| Interest Income | — | — | — | 6,830USD | — | — |
| Research Development | — | — | — | — | 343,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 57,921,471USD | 60,966,527USD | 69,385,481USD | 73,183,401USD | 77,193,993USD | 83,154,408USD | 79,598,822USD | 82,440,576USD |
| Other Current Assets | 24,917,707USD | 25,636,865USD | 25,776,950USD | 31,150,167USD | 42,943,106USD | 46,939,712USD | 30,137,426USD | 22,353,908USD |
| Total Liab | 42,427,098USD | 45,886,935USD | 46,663,932USD | 49,921,658USD | 57,255,917USD | 62,476,289USD | 59,123,273USD | 59,230,138USD |
| Total Stockholder Equity | 15,469,373USD | 15,054,592USD | 22,696,549USD | 23,236,743USD | 19,913,076USD | 20,653,119USD | 20,450,549USD | 23,185,438USD |
| Other Current Liab | 26,441,390USD | 28,237,325USD | 29,131,235USD | 30,878,930USD | 38,633,571USD | 44,260,886USD | 27,502,264USD | 21,296,329USD |
| Common Stock | 15,739USD | 15,471USD | 15,433USD | 15,364USD | 15,344USD | 15,192USD | 14,991USD | 14,996USD |
| Capital Stock | 15,739USD | 15,471USD | 15,433USD | 15,364USD | 15,344USD | 15,192USD | 14,991USD | 14,996USD |
| Retained Earnings | -23,496,070USD | -24,795,205USD | -25,786,302USD | -26,641,311USD | -29,633,990USD | -27,702,470USD | -27,720,135USD | -24,554,996USD |
| Other Assets | 1USD | — | — | — | — | 1,055,582USD | — | 1USD |
| Cash | 21,426,744USD | 23,601,810USD | 30,713,135USD | 29,811,667USD | 21,918,175USD | 25,051,355USD | 20,737,769USD | 17,457,625USD |
| Cash And Short Term Investments | 21,426,744USD | 23,601,810USD | 30,713,135USD | 29,811,667USD | 21,918,175USD | 25,051,355USD | 20,737,769USD | 17,457,625USD |
| Total Current Assets | 48,688,255USD | 52,088,539USD | 59,391,113USD | 63,752,556USD | 67,831,378USD | 74,577,448USD | 55,170,858USD | 43,387,317USD |
| Total Current Liabilities | 30,170,707USD | 32,816,581USD | 33,048,676USD | 35,510,684USD | 42,707,086USD | 49,042,087USD | 38,288,775USD | 34,014,106USD |
| Current Deferred Revenue | 2,487,723USD | 2,796,412USD | 2,520,824USD | 2,860,202USD | 2,810,485USD | 2,546,926USD | 6,010,928USD | 7,240,063USD |
| Net Debt | -19,384,455USD | -21,592,104USD | -28,621,937USD | -27,640,314USD | -19,667,581USD | -24,256,329USD | -11,313,251USD | -3,389,672USD |
| Short Term Debt | 280,253USD | 194,179USD | 191,641USD | 189,142USD | 240,889USD | 483,337USD | 3,249,199USD | 3,837,873USD |
| Short Long Term Debt Total | 2,042,289USD | 2,009,706USD | 2,091,198USD | 2,171,353USD | 2,250,594USD | 795,026USD | 9,424,518USD | 14,067,953USD |
| Net Receivables | 2,343,804USD | 2,849,864USD | 2,901,028USD | 2,790,722USD | 2,970,097USD | 2,586,381USD | 4,295,663USD | 3,575,784USD |
| Accounts Payable | 961,341USD | 1,588,665USD | 1,204,976USD | 1,582,410USD | 1,022,141USD | 1,750,938USD | 1,526,384USD | 1,639,841USD |
| Property Plant Equipment Net | 4,556,099USD | 4,731,399USD | 4,665,887USD | 4,862,375USD | 4,804,412USD | 3,762,290USD | 13,811,890USD | 20,788,350USD |
| Property Plant Equipment Gross | 12,450,417USD | 12,243,231USD | 11,754,466USD | 11,522,699USD | 11,092,539USD | 9,363,405USD | 26,715,380USD | 34,652,118USD |
| Common Stock Shares Outstanding | 14,185,152shares | 14,580,963shares | 15,398,594shares | 15,400,408shares | 15,263,152shares | 14,964,854shares | 15,138,148shares | 14,950,082shares |
| Non Current Assets Total | 9,233,215USD | 8,877,988USD | 9,994,368USD | 9,430,845USD | 9,362,615USD | 8,576,960USD | 24,427,964USD | 39,053,259USD |
| Non Current Liabilities Total | 12,256,391USD | 13,070,354USD | 13,615,255USD | 14,410,974USD | 14,548,831USD | 13,434,202USD | 20,834,498USD | 25,216,032USD |
| Non Currrent Assets Other | 4,677,116USD | 4,146,589USD | 5,328,481USD | 4,568,470USD | 4,558,203USD | 4,814,670USD | 5,414,471USD | 5,535,033USD |
| Net Working Capital | 19,420,557USD | 19,271,958USD | 27,453,684USD | 28,241,872USD | 25,124,292USD | 22,840,746USD | 16,882,083USD | 9,373,211USD |
| Unclassified Non Current Liabilities | 12,256,391USD | 13,070,354USD | 13,615,255USD | 14,410,974USD | 14,548,831USD | 13,434,202USD | 19,599,257USD | 23,980,791USD |
| Unclassified Equity | 38,933,965USD | 39,818,855USD | 48,451,985USD | 49,847,326USD | 49,516,378USD | 48,325,205USD | 48,140,702USD | 47,710,442USD |
| Short Term Investments | — | — | — | — | — | 25,051,329,948,645USD | — | — |
| Unclassified Current Assets | — | — | — | — | — | -25,051,329,948,645USD | — | — |
| Unclassified Non Current Assets | — | — | — | — | — | -1,055,582USD | — | — |
| Good Will | — | — | — | — | — | — | 4,237,945USD | 7,677,695USD |
| Non Current Liabilities Other | — | — | — | — | — | — | 1,235,241USD | 1,235,241USD |
| Intangible Assets | — | — | — | — | — | — | — | 4,145,162USD |
| Accumulated Other Comprehensive Income | — | — | — | — | — | — | — | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 60,966,527USD | 83,154,408USD | 87,208,012USD | 93,490,377USD | 87,061,747USD | 65,879,367USD | 43,705,667USD | 23,526,352USD |
| Other Current Assets | 25,636,865USD | 46,939,712USD | 23,601,340USD | 3,957,770USD | 3,662,571USD | 2,728,947USD | 1,122,478USD | 1,780,764USD |
| Total Liab | 45,886,935USD | 62,476,289USD | 62,436,130USD | 60,902,534USD | 56,753,063USD | 44,753,115USD | 37,985,167USD | 21,165,108USD |
| Total Stockholder Equity | 15,054,592USD | 20,653,119USD | 24,746,882USD | 32,562,843USD | 30,283,684USD | 21,126,152USD | 5,720,400USD | 2,361,244USD |
| Other Current Liab | 28,237,325USD | 44,260,886USD | 29,391,111USD | 4,502,765USD | 6,641,496USD | 4,501,810USD | 3,765,496USD | 7,919,853USD |
| Common Stock | 15,471USD | 15,192USD | 14,783USD | 14,560USD | 14,450USD | 14,174USD | 13,899USD | 13,757USD |
| Capital Stock | 15,471USD | 15,192USD | 14,783USD | 14,560USD | 14,450USD | 14,174USD | 13,899USD | 13,757USD |
| Retained Earnings | -24,795,205USD | -27,702,470USD | -21,905,577USD | -12,153,380USD | -12,780,085USD | -20,094,912USD | -33,637,395USD | -35,750,908USD |
| Cash | 23,601,810USD | 25,051,355USD | 18,153,609USD | 9,745,066USD | 19,526,119USD | 20,554,258USD | 8,455,989USD | 8,716,874USD |
| Cash And Short Term Investments | 23,601,810USD | 25,051,355USD | 18,153,609USD | 9,745,066USD | 19,526,119USD | 20,554,258USD | 8,455,989USD | 8,716,874USD |
| Total Current Assets | 52,088,539USD | 74,577,448USD | 44,335,538USD | 17,614,108USD | 26,889,500USD | 25,346,426USD | 13,303,672USD | 11,711,345USD |
| Total Current Liabilities | 32,816,581USD | 49,042,087USD | 33,574,082USD | 23,217,017USD | 21,438,399USD | 18,456,999USD | 13,566,314USD | 8,738,123USD |
| Current Deferred Revenue | 2,796,412USD | 2,546,926USD | 2,516,554USD | 10,427,400USD | 8,427,637USD | 6,676,924USD | 5,937,618USD | 3,364,734USD |
| Net Debt | -21,592,104USD | -24,256,329USD | -15,292,700USD | 16,311,423USD | 4,097,611USD | -2,072,500USD | 5,816,811USD | -7,616,874USD |
| Short Term Debt | 194,179USD | 483,337USD | 412,601USD | 5,320,263USD | 4,663,698USD | 5,716,617USD | 2,337,362USD | 1,100,000USD |
| Short Long Term Debt Total | 2,009,706USD | 795,026USD | 2,860,909USD | 26,056,489USD | 23,623,730USD | 18,481,758USD | 14,272,800USD | 1,100,000USD |
| Net Receivables | 2,849,864USD | 2,586,381USD | 2,580,589USD | 3,911,272USD | 3,700,810USD | 2,063,221USD | 2,773,809USD | 955,967USD |
| Accounts Payable | 1,588,665USD | 1,750,938USD | 1,253,816USD | 2,966,589USD | 1,705,568USD | 1,561,648USD | 1,525,838USD | 1,253,274USD |
| Property Plant Equipment Net | 4,731,399USD | 3,762,290USD | 4,272,155USD | 38,062,351USD | 32,814,862USD | 20,328,804USD | 19,068,260USD | 3,658,008USD |
| Property Plant Equipment Gross | 12,243,231USD | 9,363,405USD | 35,462,997USD | 38,062,351USD | 31,636,874USD | 20,328,804USD | 19,068,260USD | 3,658,008USD |
| Common Stock Shares Outstanding | 15,134,215shares | 15,147,247shares | 14,688,115shares | 14,868,093shares | 14,935,577shares | 14,582,877shares | 14,467,567shares | 14,031,717shares |
| Non Current Assets Total | 8,877,988USD | 8,576,960USD | 42,872,474USD | 75,876,269USD | 60,172,249USD | 40,532,941USD | 30,401,995USD | 11,815,007USD |
| Non Current Liabilities Total | 13,070,354USD | 13,434,202USD | 28,862,048USD | 37,685,517USD | 35,314,664USD | 26,296,116USD | 24,418,853USD | 12,426,985USD |
| Non Currrent Assets Other | 4,146,589USD | 4,814,670USD | 25,194,867USD | 6,464,064USD | 6,072,622USD | 4,772,092USD | 3,963,483USD | 3,606,513USD |
| Net Working Capital | 19,271,958USD | 22,840,746USD | 10,761,456USD | -5,504,865USD | 3,771,258USD | 6,448,060USD | -262,642USD | 2,973,222USD |
| Unclassified Non Current Liabilities | 13,070,354USD | 13,434,202USD | 25,626,807USD | -21,396,320USD | 12,295,861USD | -17,871,731USD | -12,483,415USD | -3,267,525USD |
| Unclassified Equity | 39,818,855USD | 48,325,205USD | 46,622,893USD | 44,687,103USD | 43,885,707USD | 41,335,827USD | 39,441,038USD | 43,084,496USD |
| Intangible Assets | — | — | 5,020,926USD | 10,928,295USD | 4,712,763USD | 2,865,006USD | 3,219,791USD | 1,634,060USD |
| Good Will | — | — | 7,352,878USD | 8,493,407USD | 5,085,203USD | 4,625,604USD | 4,150,461USD | 2,916,426USD |
| Other Assets | — | — | -1,047,429USD | 18,392,216USD | -2USD | 24,361,160USD | 3,963,483USD | 3,606,513USD |
| Long Term Debt | — | — | 2,000,000USD | 2,000,000USD | 2,000,000USD | 2,000,000USD | — | — |
| Accumulated Other Comprehensive Income | — | — | 0USD | 0USD | 0USD | 0USD | 0USD | -4,909,002USD |
| Non Current Liabilities Other | — | — | 1,235,241USD | 34,424,868USD | 27,231USD | 24,296,116USD | 24,328,990USD | 389,362USD |
| Unclassified Non Current Assets | — | — | 1,031,648USD | -6,464,064USD | 11,486,799USD | -16,419,725USD | -3,963,483USD | -3,606,513USD |
| Deferred Long Term Liab | — | — | — | 5,707,678USD | 5,505,420USD | 4,340,756USD | 89,863USD | 2,878,163USD |
| Other Liab | — | — | — | 16,949,291USD | 15,486,152USD | 13,530,975USD | 12,483,415USD | 12,426,985USD |
| Inventory | — | — | — | 1,859,411USD | 1,380,806USD | 1,162,922USD | 951,396USD | 749,125USD |
| Net Tangible Assets | — | — | — | 32,374,331USD | 19,048,493USD | 20,750,983USD | 5,720,400USD | 2,361,244USD |
| Unclassified Current Assets | — | — | — | -1,859,411USD | -1,380,806USD | -1,162,922USD | — | — |
| Short Long Term Debt | — | — | — | — | 2,000,000USD | 2,727,970USD | — | 1,100,000USD |
| Treasury Stock | — | — | — | — | -850,838USD | -143,111USD | -111,041USD | -90,856USD |
| Unclassified Current Liabilities | — | — | — | — | -2,000,000USD | -2,727,970USD | — | -5,999,738USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 1,102,791USD | 824,731USD | 290,370USD | 93,363USD | 801,430USD | -2,715,285USD | -3,165,139USD | -3,596,398USD |
| Depreciation | 396,693USD | 442,943USD | 446,736USD | 419,414USD | 388,316USD | 555,185USD | 1,239,234USD | 1,523,813USD |
| Stock Based Compensation | 280,000USD | 326,295USD | 346,209USD | 330,988USD | 293,941USD | 203,295USD | 430,250USD | 552,065USD |
| Other Non Cash Items | 665,812USD | 1,909,625USD | 1,853,962USD | 1,682,768USD | 1,201,578USD | 4,933,492USD | 3,778,779USD | 1,401,248USD |
| Change To Account Receivables | 460,366USD | 70,528USD | -94,157USD | 95,629USD | 1,462,554USD | -1,886,059USD | 155,120USD | -367,263USD |
| Change In Working Capital | -3,641,466USD | -699,178USD | -818,036USD | -1,657,884USD | -6,385,919USD | 1,276,973USD | 1,221,577USD | -907,786USD |
| Total Cash From Operating Activities | -1,476,170USD | 2,897,482USD | 1,773,032USD | 868,649USD | -3,700,654USD | 4,130,114USD | 3,448,062USD | -973,456USD |
| Capital Expenditures | -234,600USD | -349,400USD | -317,842USD | -505,040USD | -331,505USD | -284,253USD | -243,944USD | -262,404USD |
| Free Cash Flow | -1,710,770USD | 2,548,082USD | 1,455,190USD | 363,609USD | -4,032,159USD | 3,845,861USD | 3,204,118USD | -1,235,860USD |
| Total Cashflows From Investing Activities | -234,600USD | -349,400USD | -317,840USD | 7,233,147USD | -291,405USD | -104,253USD | -93,944USD | -88,404USD |
| Net Borrowings | 0USD | 0USD | 0USD | 0USD | -4,354USD | -6,471USD | -6,403USD | — |
| Total Cash From Financing Activities | -1,164,354USD | -8,959,349USD | -1,741,412USD | 0USD | 893,182USD | -24,861USD | -6,403USD | 42,739USD |
| Sale Purchase Of Stock | -1,201,582USD | -9,024,589USD | -2,288,994USD | — | -8,440USD | — | — | -3,021USD |
| Change In Cash | -2,875,124USD | -6,411,267USD | -286,220USD | 8,101,796USD | -3,098,877USD | 4,001,000USD | 3,347,715USD | -1,019,121USD |
| Begin Period Cash Flow | 24,301,868USD | 30,713,135USD | 30,999,355USD | 22,897,559USD | 25,996,436USD | 21,995,436USD | 18,647,721USD | 19,666,842USD |
| End Period Cash Flow | 21,426,744USD | 24,301,868USD | 30,713,135USD | 30,999,355USD | 22,897,559USD | 25,996,436USD | 21,995,436USD | 18,647,721USD |
| Other Cashflows From Financing Activities | -1,164,354USD | — | -1,741,412USD | — | 905,976USD | -18,390USD | -6,403USD | 49,077USD |
| Unclassified Financing Cash Flow | 1,201,582USD | — | 2,288,994USD | — | — | — | — | — |
| Other Cashflows From Investing Activities | — | -7,818,387USD | 7,778,287USD | — | 40,100USD | — | 374,100USD | 174,000USD |
| Unclassified Investing Cash Flow | — | 7,818,387USD | -7,460,445USD | — | — | — | — | — |
| Investments | — | — | -317,840USD | 7,233,147USD | -291,405USD | -104,253USD | -93,944USD | -88,404USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 2,907,265USD | -8,529,843USD | -9,752,197USD | 1,177,250USD | 7,565,047USD | 13,167,314USD | 3,323,712USD | 253,083USD |
| Depreciation | 1,713,719USD | 4,722,137USD | 8,582,203USD | 7,643,980USD | 3,921,887USD | 2,734,462USD | 1,899,257USD | 1,556,240USD |
| Stock Based Compensation | 1,297,433USD | 1,679,005USD | 1,737,682USD | 1,273,989USD | 1,056,015USD | 885,975USD | 720,651USD | 628,430USD |
| Other Non Cash Items | 5,388,043USD | 10,495,082USD | 2,414,777USD | 341,678USD | -7,770USD | -6,037,747USD | -18,890USD | 308,978USD |
| Change To Account Receivables | 1,534,554USD | -1,645,078USD | 192,348USD | -154,672USD | -1,637,589USD | 794,586USD | -1,838,735USD | -75,327USD |
| Change In Working Capital | -9,561,017USD | 1,104,225USD | 798,620USD | -99,234USD | 3,087,058USD | 433,238USD | 1,595,438USD | 2,782,557USD |
| Total Cash From Operating Activities | 1,838,509USD | 9,415,050USD | 14,677,589USD | 11,084,584USD | 13,844,080USD | 11,183,242USD | 7,521,949USD | 5,452,268USD |
| Capital Expenditures | -1,503,785USD | -1,185,647USD | -4,999,070USD | -8,774,080USD | -6,989,534USD | -3,156,233USD | -4,165,078USD | -1,389,367USD |
| Free Cash Flow | 334,724USD | 8,229,403USD | 9,678,519USD | 2,310,504USD | 6,854,546USD | 8,027,009USD | 3,356,871USD | 4,062,901USD |
| Total Cashflows From Investing Activities | 6,274,502USD | -631,547USD | -6,187,835USD | -20,775,115USD | -12,754,669USD | -4,601,009USD | -7,138,062USD | -1,243,654USD |
| Net Borrowings | -4,354USD | -2,025,484USD | -24,432USD | -49,855USD | -2,808,292USD | 1,947,352USD | -1,100,000USD | -1,121,954USD |
| Total Cash From Financing Activities | -9,807,579USD | -2,001,359USD | 174,121USD | 328,610USD | -1,996,702USD | 5,595,519USD | -596,962USD | 326,298USD |
| Sale Purchase Of Stock | -11,322,023USD | -9,583USD | -3,833USD | -5,804USD | -707,727USD | -32,070USD | -20,185USD | -4,811USD |
| Change In Cash | -1,694,568USD | 6,782,144USD | 8,663,875USD | -9,361,921USD | -907,291USD | 12,177,752USD | -213,075USD | 4,534,912USD |
| Begin Period Cash Flow | 25,996,436USD | 19,214,292USD | 10,550,417USD | 19,912,338USD | 20,819,629USD | 8,641,877USD | 8,854,952USD | 4,320,040USD |
| End Period Cash Flow | 24,301,868USD | 25,996,436USD | 19,214,292USD | 10,550,417USD | 19,912,338USD | 20,819,629USD | 8,641,877USD | 8,854,952USD |
| Unclassified Investing Cash Flow | 7,778,287USD | — | 12,180,569USD | 23,650,115USD | 15,532,069USD | — | -3,271,680USD | — |
| Unclassified Financing Cash Flow | 1,518,798USD | — | — | — | 2,227,044USD | — | — | 1,126,765USD |
| Investments | — | -631,547USD | -13,369,334USD | -20,775,115USD | -14,143,369USD | 128,724USD | 149,348USD | 245,713USD |
| Other Cashflows From Investing Activities | — | 554,100USD | — | -14,876,035USD | -7,153,835USD | -910,776USD | 149,348USD | 245,713USD |
| Other Cashflows From Financing Activities | — | 24,125USD | 198,553USD | 384,269USD | 811,590USD | 3,737,334USD | 545,177USD | 326,298USD |
| Dividends Paid | — | — | -202,386USD | -384,269USD | -1,519,317USD | -1,009,363USD | -545,177USD | — |
| Unclassified Operating Cash Flow | — | — | 10,896,504USD | — | -1,778,157USD | — | — | — |
| Change To Liabilities | — | — | — | -1,817,674USD | 3,217,083USD | 934,206USD | 3,435,480USD | 1,461,718USD |
| Cash And Cash Equivalents Changes | — | — | — | -9,361,921USD | -907,291USD | 12,177,752USD | -213,075USD | 4,534,912USD |
| Change To Inventory | — | — | — | — | 1,851,172USD | 537,710USD | 3,387,768USD | 1,111,562USD |
| Issuance Of Capital Stock | — | — | — | — | — | — | — | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q1 2026Quarterly · 2026-03-31 | Product | Advertising Services | 3,647,083 | USD | 0001612630-26-000051 |
| Q1 2026Quarterly · 2026-03-31 | Product | Franchise | 1,145,068 | USD | 0001612630-26-000051 |
| Q1 2026Quarterly · 2026-03-31 | Product | Product And Service Other | 460,892 | USD | 0001612630-26-000051 |
| Q1 2026Quarterly · 2026-03-31 | Product | Royalty | 8,032,289 | USD | 0001612630-26-000051 |
| Q1 2026Quarterly · 2026-03-31 | Product | Technology Service | 1,534,901 | USD | 0001612630-26-000051 |
| Q4 2025Quarterly · 2025-12-31 | Product | Advertising Services | 3,466,251 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Franchise | 810,089 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Product And Service Other | 449,418 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Royalty | 8,892,863 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Technology Service | 1,548,426 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Product | Advertising Services | 10,451,281 | USD | 0001612630-26-000022 |
| FY 2025Yearly · 2025-12-31 | Product | Franchise | 3,371,504 | USD | 0001612630-26-000022 |
| FY 2025Yearly · 2025-12-31 | Product | Product And Service Other | 1,831,537 | USD | 0001612630-26-000022 |
| FY 2025Yearly · 2025-12-31 | Product | Royalty | 33,203,885 | USD | 0001612630-26-000022 |
| FY 2025Yearly · 2025-12-31 | Product | Technology Service | 6,037,385 | USD | 0001612630-26-000022 |
| Q3 2025Quarterly · 2025-09-30 | Product | Advertising Services | 2,344,833 | USD | 0001612630-25-000068 |
| Q3 2025Quarterly · 2025-09-30 | Product | Franchise | 964,796 | USD | 0001612630-25-000068 |
| Q3 2025Quarterly · 2025-09-30 | Product | Product And Service Other | 418,810 | USD | 0001612630-25-000068 |
| Q3 2025Quarterly · 2025-09-30 | Product | Royalty | 8,106,915 | USD | 0001612630-25-000068 |
| Q3 2025Quarterly · 2025-09-30 | Product | Technology Service | 1,545,331 | USD | 0001612630-25-000068 |
| Q2 2025Quarterly · 2025-06-30 | Product | Advertising Services | 2,332,695 | USD | 0001612630-25-000037 |
| Q2 2025Quarterly · 2025-06-30 | Product | Franchise | 768,100 | USD | 0001612630-25-000037 |
| Q2 2025Quarterly · 2025-06-30 | Product | Product And Service Other | 554,692 | USD | 0001612630-25-000037 |
| Q2 2025Quarterly · 2025-06-30 | Product | Royalty | 8,133,122 | USD | 0001612630-25-000037 |
| Q2 2025Quarterly · 2025-06-30 | Product | Technology Service | 1,481,661 | USD | 0001612630-25-000037 |
| Q1 2025Quarterly · 2025-03-31 | Product | Advertising Services | 2,307,502 | USD | 0001612630-26-000051 |
| Q1 2025Quarterly · 2025-03-31 | Product | Franchise | 828,519 | USD | 0001612630-26-000051 |
| Q1 2025Quarterly · 2025-03-31 | Product | Product And Service Other | 408,617 | USD | 0001612630-26-000051 |
| Q1 2025Quarterly · 2025-03-31 | Product | Royalty | 8,070,985 | USD | 0001612630-26-000051 |
| Q1 2025Quarterly · 2025-03-31 | Product | Technology Service | 1,461,967 | USD | 0001612630-26-000051 |
| Q4 2024Quarterly · 2024-12-31 | Product | Advertising Services | 2,525,307 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Franchise | 925,185 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Product And Service Other | 968,709 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Royalty | 8,840,888 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Technology Service | 1,454,193 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Product | Advertising Services | 9,180,281 | USD | 0001612630-26-000022 |
| FY 2024Yearly · 2024-12-31 | Product | Franchise | 2,997,850 | USD | 0001612630-26-000022 |
| FY 2024Yearly · 2024-12-31 | Product | Product And Service Other | 2,153,177 | USD | 0001612630-26-000022 |
| FY 2024Yearly · 2024-12-31 | Product | Royalty | 32,144,796 | USD | 0001612630-26-000022 |
| FY 2024Yearly · 2024-12-31 | Product | Technology Service | 5,687,326 | USD | 0001612630-26-000022 |
| Q3 2024Quarterly · 2024-09-30 | Product | Advertising Services | 2,247,663 | USD | 0001612630-25-000068 |
| Q3 2024Quarterly · 2024-09-30 | Product | Franchise | 697,688 | USD | 0001612630-25-000068 |
| Q3 2024Quarterly · 2024-09-30 | Product | Product And Service Other | 407,691 | USD | 0001612630-25-000068 |
| Q3 2024Quarterly · 2024-09-30 | Product | Royalty | 7,870,033 | USD | 0001612630-25-000068 |
| Q3 2024Quarterly · 2024-09-30 | Product | Technology Service | 1,431,321 | USD | 0001612630-25-000068 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Corporate Clinics | 17,544,658 | USD | 0001628280-24-046464 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Franchise Operations | 12,653,832 | USD | 0001628280-24-046464 |
| Q2 2024Quarterly · 2024-06-30 | Product | Advertising Services | 2,240,839 | USD | 0001612630-25-000037 |
| Q2 2024Quarterly · 2024-06-30 | Product | Franchise | 719,103 | USD | 0001612630-25-000037 |
| Q2 2024Quarterly · 2024-06-30 | Product | Product And Service Other | 388,730 | USD | 0001612630-25-000037 |
| Q2 2024Quarterly · 2024-06-30 | Product | Royalty | 7,846,328 | USD | 0001612630-25-000037 |
| Q2 2024Quarterly · 2024-06-30 | Product | Technology Service | 1,415,036 | USD | 0001612630-25-000037 |
| Q2 2024Quarterly · 2024-06-30 | Segment | Corporate Clinics | 17,648,736 | USD | 0001628280-24-036301 |
| Q2 2024Quarterly · 2024-06-30 | Segment | Franchise Operations | 12,611,825 | USD | 0001628280-24-036301 |
| Q1 2024Quarterly · 2024-03-31 | Segment | Corporate Clinics | 17,537,504 | USD | 0001612630-24-000006 |
| Q1 2024Quarterly · 2024-03-31 | Segment | Franchise Operations | 12,184,662 | USD | 0001612630-24-000006 |
| FY 2023Yearly · 2023-12-31 | Product | Advertising Services | 8,321,043 | USD | 0001628280-25-012702 |
| FY 2023Yearly · 2023-12-31 | Product | Franchise | 2,882,895 | USD | 0001628280-25-012702 |
| FY 2023Yearly · 2023-12-31 | Product | Product And Service Other | 1,526,145 | USD | 0001628280-25-012702 |
| FY 2023Yearly · 2023-12-31 | Product | Royalty | 29,160,832 | USD | 0001628280-25-012702 |
| FY 2023Yearly · 2023-12-31 | Product | Technology Service | 5,086,562 | USD | 0001628280-25-012702 |
| Q4 2023Quarterly · 2023-12-31 | Segment | Corporate Clinics | 17,905,782 | USD | Legacy provider |
| Q4 2023Quarterly · 2023-12-31 | Segment | Franchise Operations | 12,708,621 | USD | Legacy provider |
| FY 2023Yearly · 2023-12-31 | Segment | Corporate Clinics | 70,718,880 | USD | 0001628280-24-009767 |
| FY 2023Yearly · 2023-12-31 | Segment | Franchise Operations | 46,977,476 | USD | 0001628280-24-009767 |
| Q3 2023Quarterly · 2023-09-30 | Segment | Corporate Clinics | 17,882,303 | USD | 0001628280-24-046464 |
| Q3 2023Quarterly · 2023-09-30 | Segment | Franchise Operations | 11,591,646 | USD | 0001628280-24-046464 |
| Q2 2023Quarterly · 2023-06-30 | Segment | Corporate Clinics | 17,802,838 | USD | 0001628280-24-036301 |
| Q2 2023Quarterly · 2023-06-30 | Segment | Franchise Operations | 11,504,346 | USD | 0001628280-24-036301 |
| Q1 2023Quarterly · 2023-03-31 | Segment | Corporate Clinics | 17,127,957 | USD | 0001612630-24-000006 |
| Q1 2023Quarterly · 2023-03-31 | Segment | Franchise Operations | 11,172,863 | USD | 0001612630-24-000006 |
| FY 2022Yearly · 2022-12-31 | Product | Advertising Services | 7,456,696 | USD | 0001628280-23-007589 |
| FY 2022Yearly · 2022-12-31 | Product | Franchise | 2,441,325 | USD | 0001628280-23-007589 |
| FY 2022Yearly · 2022-12-31 | Product | Product And Service Other | 1,450,725 | USD | 0001628280-23-007589 |
| FY 2022Yearly · 2022-12-31 | Product | Regional Developer Fees | 659,099 | USD | 0001628280-23-007589 |
| FY 2022Yearly · 2022-12-31 | Product | Revenues And Management Fees From Company Clinics | 59,422,294 | USD | 0001628280-23-007589 |
| FY 2022Yearly · 2022-12-31 | Product | Royalty | 26,190,531 | USD | 0001628280-23-007589 |
| FY 2022Yearly · 2022-12-31 | Product | Technology Service | 4,290,739 | USD | 0001628280-23-007589 |
| Q4 2022Quarterly · 2022-12-31 | Segment | Corporate Clinics | 16,485,996 | USD | Legacy provider |
| Q4 2022Quarterly · 2022-12-31 | Segment | Franchise Operations | 10,990,592 | USD | Legacy provider |
| FY 2022Yearly · 2022-12-31 | Segment | Corporate Clinics | 59,422,294 | USD | 0001628280-24-009767 |
| FY 2022Yearly · 2022-12-31 | Segment | Franchise Operations | 41,830,016 | USD | 0001628280-24-009767 |
| FY 2021Yearly · 2021-12-31 | Product | Advertising Services | 6,298,924 | USD | 0001628280-23-007589 |
| FY 2021Yearly · 2021-12-31 | Product | Franchise | 2,659,097 | USD | 0001628280-23-007589 |
| FY 2021Yearly · 2021-12-31 | Product | Product And Service Other | 1,257,913 | USD | 0001628280-23-007589 |
| FY 2021Yearly · 2021-12-31 | Product | Regional Developer Fees | 848,640 | USD | 0001628280-23-007589 |
| FY 2021Yearly · 2021-12-31 | Product | Revenues And Management Fees From Company Clinics | 44,348,234 | USD | 0001628280-23-007589 |
| FY 2021Yearly · 2021-12-31 | Product | Royalty | 22,062,989 | USD | 0001628280-23-007589 |
| FY 2021Yearly · 2021-12-31 | Product | Technology Service | 3,383,856 | USD | 0001628280-23-007589 |
| FY 2021Yearly · 2021-12-31 | Segment | Corporate Clinics | 44,348,234 | USD | 0001628280-23-007589 |
| FY 2021Yearly · 2021-12-31 | Segment | Franchise Operations | 36,511,419 | USD | 0001628280-23-007589 |
| FY 2020Yearly · 2020-12-31 | Product | Advertising Services | 4,506,413 | USD | 0001628280-22-005982 |
| FY 2020Yearly · 2020-12-31 | Product | Franchise | 2,100,800 | USD | 0001628280-22-005982 |
| FY 2020Yearly · 2020-12-31 | Product | Product And Service Other | 861,181 | USD | 0001628280-22-005982 |
| FY 2020Yearly · 2020-12-31 | Product | Regional Developer Fees | 876,804 | USD | 0001628280-22-005982 |
| FY 2020Yearly · 2020-12-31 | Product | Revenues And Management Fees From Company Clinics | 31,757,207 | USD | 0001628280-22-005982 |
| FY 2020Yearly · 2020-12-31 | Product | Royalty | 15,886,051 | USD | 0001628280-22-005982 |
| FY 2020Yearly · 2020-12-31 | Product | Technology Service | 2,694,520 | USD | 0001628280-22-005982 |
| FY 2020Yearly · 2020-12-31 | Segment | Corporate Clinics | 31,757,207 | USD | 0001628280-22-005982 |
| FY 2020Yearly · 2020-12-31 | Segment | Franchise Operations | 26,925,769 | USD | 0001628280-22-005982 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.